METHADONE HYDROCHLORIDE

Post-LOE

methadone hydrochloride

Hikma

ANDAINJECTIONINJECTABLE

Approved

Oct 2017

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

METHADONE HYDROCHLORIDE (methadone hydrochloride) by Hikma is mechanism of action methadone hydrochloride is a mu-agonist; a synthetic opioid analgesic with multiple actions qualitatively similar to those of morphine, the most prominent of which involve the central nervous system and organs composed of smooth muscle. Approved for severe, persistent pain, for which alternative treatment options are inadequate. First approved in 2017.

Drug data last refreshed 18h ago

Mechanism of Action

Mechanism of Action Methadone hydrochloride is a mu-agonist; a synthetic opioid analgesic with multiple actions qualitatively similar to those of morphine, the most prominent of which involve the central nervous system and organs composed of smooth muscle. The principal therapeutic uses for…

Indications (3)

severe persistent pain

Worked on METHADONE HYDROCHLORIDE at Hikma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.